How Sahm Adrangi’s Kerrisdale Capital Management is Ripping Benefits from Short-selling Stocks

Investors of Kerrisdale Capital Management recently placed a bet on a single share of Kerrisdale’s unnamed company. The bet amounted to $100. Kerrisdale Capital, which was created by Sahm Adrangi, is now regarded as the first hedge fund manager to raise such a fund. Hedge fund managers refer the fund to as a “co-investment” fund. Kerrisdale plans to utilize the fund in shorting a single stock of the soon-to-be-announced publicly-traded company.

Sahm Adrangi wrote to the investors regarding his firm’s future business objectives. He told them that his company made history when it raised a huge amount of money in a short time. He also informed them that Kerrisdale is on a mission to let everyone understands its present and plans. In reference to the email Adrangi sent to investors, Kerrisdale Capital is reported to be worth over $10 billion.

Besides Sahm Adrangi, Kerrisdale’s management team also comprises of an analyst by the name Shane Wilson. Adrangi and Wilson have joined forces to develop an informative campaign targeting Kerrisdale’s clients, investors, and partners. This campaign is expected to be amplified by a new website, video, and report.

Kerrisdale Capital Management currently has assets with a worth of $500 million under its belt. The company has gained critically-acclaim severally for inviting investors to bet against publicly-traded companies. Among the companies that Kerrisdale’s investors betted on include Zagfen and Sage Therapeutics. Kerrisdale Capital earns yearly returns of over 28 percent of the betted stocks.

About Sahm Adrangi

Sahm Adrangi has been part of Kerrisdale’s investment management operations as the chief investment officer. His strengths lie in shorting stocks and carrying out short-selling research. Adrangi also earned popularity due to his efforts to expose firms that failed to abide by the regulations of the SEC. These companies included China-Biotics and China Cast Education Corporation.

Through Kerrisdale Capital Management, Sahm Adrangi carries out and shares research on the mining and biotechnology sectors. His recent research interests were on biotech companies like Zafgen, Pulse Biosciences, and Bavarian Nordic. In the mining sector, he has focused on companies like Northern Dynasty Minerals and First Majestic Silver. He also shares his views regarding telecom companies like Path Communications, Dish Network, Viasat, and Globalstar.